3.9 | | KIZ | 'wild type; BREFELDIN A' vs 'wild type; control' | genotype, treatment | Induction of ER stress in HCT116 colon cancer cells |
-3.1 | | KIZ | 'Staphylococcus aureus strain 10254' at '6 hour' vs 'none' at '0 hour' | time, treatment | Transcription profiling by array of human peripheral blood mononuclear cells after treatment with community-associated Staphylococcus aureus and incubation for different lengths of time |
-3 | | KIZ | 'blood alcohol content 0.04%rising' vs 'control' in 'time point 2' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
-3 | | KIZ | 'Staphylococcus aureus strain Col' at '6 hour' vs 'none' at '0 hour' | time, treatment | Transcription profiling by array of human peripheral blood mononuclear cells after treatment with community-associated Staphylococcus aureus and incubation for different lengths of time |
-2.9 | | KIZ | 'blood alcohol content 0.02%declining' vs 'control' in 'time point 5' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
-2.9 | | KIZ | 'Staphylococcus aureus strain 9897' at '6 hour' vs 'none' at '0 hour' | time, treatment | Transcription profiling by array of human peripheral blood mononuclear cells after treatment with community-associated Staphylococcus aureus and incubation for different lengths of time |
-2.9 | | KIZ | 'Staphylococcus aureus strain 11490' at '6 hour' vs 'none' at '0 hour' | time, treatment | Transcription profiling by array of human peripheral blood mononuclear cells after treatment with community-associated Staphylococcus aureus and incubation for different lengths of time |
-2.8 | | KIZ | 'lipopolysaccharide' vs 'none' in 'systemic-onset juvenile idiopathic arthritis' | disease, stimulus | A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis [RNA-Seq] |
-2.8 | | KIZ | 'blood alcohol content 0.08%' vs 'control' in 'time point 3' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
-2.8 | | KIZ | 'ChiPS4; hepatocyte-like cell' vs 'ChiPS4; induced pluripotent stem cell' | block, cell line, cell type, fraction | Gene expression profile of human embryonic stem cell-derived hepatocyte-like cells |
-2.8 | | KIZ | 'SW-620; adenocarcinoma of colon; P10' vs 'SW-620; adenocarcinoma of colon; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
2.8 | | KIZ | 'wild type; tunicamycin' vs 'wild type; control' | genotype, treatment | Induction of ER stress in HCT116 colon cancer cells |
-2.7 | | KIZ | 'SA181; hepatocyte-like cell' vs 'SA181; embryonic stem cell' | block, cell line, cell type, fraction | Gene expression profile of human embryonic stem cell-derived hepatocyte-like cells |
2.7 | | KIZ | 'p53KO; tunicamycin' vs 'p53KO; control' | genotype, treatment | Induction of ER stress in HCT116 colon cancer cells |
-2.6 | | KIZ | 'lipopolysaccharide' vs 'none' in 'normal' | disease, stimulus | A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis [RNA-Seq] |
-2.6 | | KIZ | 'blood alcohol content 0.04%declining' vs 'control' in 'time point 4' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
-2.6 | | KIZ | 'transduced with HOXA1' vs 'control' | treatment | Gene expression profiling of enforced HOXA1 expression in melanoma cell line |
2.6 | | KIZ | '25 milligram; Asoprisnil' vs 'placebo' in 'endometrium' | compound, organism part | Regulation of endometrial bleeding by uNK cells |
-2.6 | | KIZ | 'myeloid-related protein 8' vs 'control' on 'Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]' | stimulus | Transcription profiling by array of human blood monocyte stimulated with various stimuli (control, MRP8, LPS, TNF, IL1) to study signalling pathways in phagocytic activation |
-2.5 | | KIZ | '12 hour' vs '0 hour' in 'MCF-10A-H1047R' | cell line, time | Knock-in of PIK3CA-H1047R into MCF-10A |
-2.5 | | KIZ | 'blood alcohol content 0%' vs 'control' in 'time point 1' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
-2.4 | | KIZ | '24 hour' vs '0 hour' in 'MCF-10A' | cell line, time | Knock-in of PIK3CA-H1047R into MCF-10A |
2.4 | | KIZ | 'metastatic recurrence; tumor' vs 'metastatic recurrence; normal adjacent tissue' | clinical information, sampling site | Gene expression profile of primary colorectal tumors with and without distant metastasis |
-2.3 | | KIZ | 'SW-620; adenocarcinoma of colon; P04' vs 'SW-620; adenocarcinoma of colon; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
-2.3 | | KIZ | 'Francisella tularensis novicida' vs 'uninfected' | infect | Transcription profiling by array of human peripheral blood mononuclear cells infected with Francisella tularensis |
2.3 | | KIZ | 'DICERER5/EX5; tunicamycin' vs 'DICERER5/EX5; control' | genotype, treatment | Induction of ER stress in HCT116 colon cancer cells |
-2.2 | | KIZ | 'injected in NSG mouse' vs 'none' in 'none' | stimulus, xenograft | RNA-Seq of T cells sorted from human PBMCs, or from T cells stimulated with CD3/CD28 beads for 4 days, or from the spleen of NSG or NSG-HLA-A2/HHD mice, 7 days after transplantation with human PBMCs |
-2.2 | | KIZ | '12 hour' vs '0 hour' in 'MCF-10A' | cell line, time | Knock-in of PIK3CA-H1047R into MCF-10A |
-2.2 | | KIZ | 'Staphylococcus aureus strain 252' at '6 hour' vs 'none' at '0 hour' | time, treatment | Transcription profiling by array of human peripheral blood mononuclear cells after treatment with community-associated Staphylococcus aureus and incubation for different lengths of time |
-2.1 | | KIZ | 'injected in NSG-HLA-A2/HHD mouse' vs 'none' in 'none' | stimulus, xenograft | RNA-Seq of T cells sorted from human PBMCs, or from T cells stimulated with CD3/CD28 beads for 4 days, or from the spleen of NSG or NSG-HLA-A2/HHD mice, 7 days after transplantation with human PBMCs |
2.1 | | KIZ | 'cells p16-transfected' vs 'control' | treatment | Induction of apoptotic processes in Capan-1 pancreatic carcinoma cells by restoration of p16INK4a expression |
-2 | | KIZ | 'human intestinal organoids derived from H9 stem cells' vs 'Undifferentiated H9 Stem Cells' | cell type | Transcriptional Profiling of human pluripotent stem cells and and derived tissues |
-2 | | KIZ | 'deferoxamine; 100 nanomolar echinomycin' vs 'deferoxamine; none' | growth condition, treatment | Transcription profiling by array of human glioblastoma cells after stimulation with deferoxamine and treatment with polyamide 1, echinomycin, or HIF-1a siRNA |
2 | | KIZ | 'BEZ235; max' vs 'DMSO; ' | compound | Comparison of gene expression alterations induced by distinct PI3K inhibitors |
-2 | | KIZ | 'SW-620; adenocarcinoma of colon; P01' vs 'SW-620; adenocarcinoma of colon; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
-2 | | KIZ | 'tumor necrosis factor alpha' vs 'control' on 'Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]' | stimulus | Transcription profiling by array of human blood monocyte stimulated with various stimuli (control, MRP8, LPS, TNF, IL1) to study signalling pathways in phagocytic activation |
-1.9 | | KIZ | '24 hour' vs '0 hour' in 'MCF-10A-H1047R' | cell line, time | Knock-in of PIK3CA-H1047R into MCF-10A |
-1.9 | | KIZ | 'stimulation' vs 'control' | growth condition | Effect of human breast tumor supernatant on normal CD4+ T cells (Confirmation Set SN) |
1.9 | | KIZ | 'plateau transepithelial electrical resistance' vs 'monolayer control' | phenotype | Gene Expression in MCF10A cells through Differentiation on Transwells |
-1.9 | | KIZ | 'ovarian cancer' vs 'normal' in 'epithelial cell' | cell type, disease | A cancer associated fibroblasts (CAFs) specific gene signature in high grade serous ovarian cancer |
1.9 | | KIZ | 'BEZ235; 90 per cent inhibitory concentration' vs 'DMSO; ' | compound | Comparison of gene expression alterations induced by distinct PI3K inhibitors |
-1.9 | | KIZ | 'PKA RII-beta over expression' vs 'wild type' | genotype | Transcription profiling by array of human ovarian cancer cells over-expressing PKA regulatory subunits |
-1.9 | | KIZ | 'DMSO' in 'stimulated with interferon gamma and lipopolysaccharide' vs 'none' at '6 hour' | compound, time, treatment | GPBAR1 agonism has a broad impact on blocking macrophage activation |
-1.9 | | KIZ | 'teratozoospermia' vs 'normospermic' | disease | Transcription profiling by array of human sperm from normospermic and teratozoospermic individuals |
-1.9 | | KIZ | 'Newcastle disease virus' at '14 hour' vs 'none' at '0 hour' | infect, time | Transcription profiling by array of human dendritic cells infected with Newcastle Disease Virus |
1.8 | | KIZ | 'lapatinib; 500 nanomolar; 1 day' vs 'dimethyl sulfoxide; 1 day' | compound, time | RNA-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib |
1.8 | | KIZ | 'Barrett’s esophagus; low-grade dysplasia' vs 'normal' | disease, disease staging | Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's |
-1.8 | | KIZ | 'ejaculatory azoospermia; Johnsen score count 2' vs 'normal; Johnsen score count 10' | disease, histology | Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis |
-1.8 | | KIZ | 'non-small cell lung carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
-1.8 | | KIZ | 'ejaculatory azoospermia; Johnsen score count 3.2' vs 'normal; Johnsen score count 10' | disease, histology | Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis |
-1.8 | | KIZ | 'AsPC-1; pancreatic adenocarcinoma; P01' vs 'AsPC-1; pancreatic adenocarcinoma; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
-1.8 | | KIZ | 'Newcastle disease virus' at '12 hour' vs 'none' at '0 hour' | infect, time | Transcription profiling by array of human dendritic cells infected with Newcastle Disease Virus |
-1.8 | | KIZ | 'Newcastle disease virus' at '16 hour' vs 'none' at '0 hour' | infect, time | Transcription profiling by array of human dendritic cells infected with Newcastle Disease Virus |
-1.8 | | KIZ | 'differention medium' vs 'proliferation medium' in 'interstitial cystitis' | disease, growth condition | Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation |
-1.7 | | KIZ | 'SNCA overexpression' vs 'wild type genotype' | genotype | RNA-seq of human midbrain organoid models of Parkinson's Disease |
-1.7 | | KIZ | 'doxycycline; 0.5 microgram per milliliter; Day 4 post Neurogenin induction' vs 'control' | compound, treatment | Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) |
-1.7 | | KIZ | 'cycloheximide; control (ethanol vehicle)' vs 'DMSO control; control (ethanol vehicle)' | compound, growth condition | Transcription profiling by array of human MCF7 breast cancer cells after growth with cyclohexamide followed by treatment with 17beta-estradiol |
-1.7 | | KIZ | 'Staphylococcus aureus strain 9897' at '3 hour' vs 'none' at '0 hour' | time, treatment | Transcription profiling by array of human peripheral blood mononuclear cells after treatment with community-associated Staphylococcus aureus and incubation for different lengths of time |
-1.7 | | KIZ | 'Newcastle disease virus' at '10 hour' vs 'none' at '0 hour' | infect, time | Transcription profiling by array of human dendritic cells infected with Newcastle Disease Virus |
-1.7 | | KIZ | 'TNF-treated' vs 'untreated' | treatment | Expression data from primary human keratinocytes exposed to cytokines in vitro (IL-4, IL-13, IL-17A, IFN-alpha, IFN-gamma, TNF) |
-1.7 | | KIZ | 'differention medium' vs 'proliferation medium' in 'normal' | disease, growth condition | Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation |
-1.6 | | KIZ | 'cisplatin; 100 micromolar' vs 'none' in 'TMEM45A knockdown by siRNA' | RNA interference, compound | RNA-seq of human head and neck cancer cell line SQD9 knock-out for TMEM45A exposed to cisplatin |
-1.6 | | KIZ | 'EX00000246; stimulated with interferon gamma and lipopolysaccharide' vs 'none' at '24 hour' | compound, time, treatment | GPBAR1 agonism has a broad impact on blocking macrophage activation |
-1.6 | | KIZ | 'heat-killed Escherichia coli' vs 'none' in 'ulcerative colitis' | disease, stimulus | Transcription profiling by array of primary human macrophages cultured from patients with ulcerative colitis or healthy individuals with or without stimulation by heat-killed E. coli |
1.6 | | KIZ | 'mid transepithelial electrical resistance' vs 'monolayer control' | phenotype | Gene Expression in MCF10A cells through Differentiation on Transwells |
1.6 | | KIZ | 'AQM' vs 'normal' on 'Affymetrix HG-U133B' | disease | Transcription profiling by array of 12 human muscle diseases |
-1.6 | | KIZ | 'Staphylococcus aureus strain Col' at '3 hour' vs 'none' at '0 hour' | time, treatment | Transcription profiling by array of human peripheral blood mononuclear cells after treatment with community-associated Staphylococcus aureus and incubation for different lengths of time |
-1.6 | | KIZ | 'heat-killed Escherichia coli' vs 'none' in 'normal' | disease, stimulus | Transcription profiling by array of primary human macrophages cultured from patients with ulcerative colitis or healthy individuals with or without stimulation by heat-killed E. coli |
-1.6 | | KIZ | 'Staphylococcus aureus strain 11490' at '3 hour' vs 'none' at '0 hour' | time, treatment | Transcription profiling by array of human peripheral blood mononuclear cells after treatment with community-associated Staphylococcus aureus and incubation for different lengths of time |
-1.5 | | KIZ | 'CD3/CD28 beads' vs 'none' in 'none' | stimulus, xenograft | RNA-Seq of T cells sorted from human PBMCs, or from T cells stimulated with CD3/CD28 beads for 4 days, or from the spleen of NSG or NSG-HLA-A2/HHD mice, 7 days after transplantation with human PBMCs |
-1.5 | | KIZ | 'doxycycline; 0.5 microgram per milliliter; Day 3 post Neurogenin induction' vs 'control' | compound, treatment | Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) |
1.5 | | KIZ | 'gefitinib; 24 hour' vs 'none; 2 hour' | compound, time | RNA-seq of A431 cell line after gefitinib treatment |
-1.5 | | KIZ | 'DMSO' in 'stimulated with interferon gamma and lipopolysaccharide' vs 'none' at '24 hour' | compound, time, treatment | GPBAR1 agonism has a broad impact on blocking macrophage activation |
1.5 | | KIZ | 'HPAF_II; CI-1040; 2 millimolar' vs 'HPAF_II; vehicle; ' | cell line, compound | Expression Data from 22 human pancreatic cancer cell lines grown in triplicates +/- MEK inhibitor CI-1040 |
-1.5 | | KIZ | '200 nanomolar retinoic acid' vs 'none' | compound | Transcription profiling by array of human embryonic stem cells response to retinoic acid exposure |
-1.5 | | KIZ | 'breast carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
1.5 | | KIZ | 'low transepithelial electrical resistance' vs 'monolayer control' | phenotype | Gene Expression in MCF10A cells through Differentiation on Transwells |
-1.5 | | KIZ | 'CLS1; 6 passages' vs 'CLS1; co-culture with CAF to generate sphere' | cell line, growth condition, passage | Cancer-Associated Fibroblasts Support Lung Cancer Stemness through Paracrine IGF-II/IGF1R/Nanog Signaling |
-1.5 | | KIZ | '10 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
-1.5 | | KIZ | 'AsPC-1; pancreatic adenocarcinoma; P04' vs 'AsPC-1; pancreatic adenocarcinoma; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
1.5 | | KIZ | 'ETP-45658' vs 'DMSO' | compound | Gene expression profiling upon PI3K inhibition using different inhibitors |
-1.5 | | KIZ | 'T-helper 2 polarising' at '1 day' vs 'no stimulus' | cell type, sampling time point, stimulus | Transcription profiling by array of human CD4+T-cells, Th1/Th2 polarized time-series and primary memory subsets |
-1.5 | | KIZ | 'T-helper 1 polarising' at '1 day' vs 'no stimulus' | cell type, sampling time point, stimulus | Transcription profiling by array of human CD4+T-cells, Th1/Th2 polarized time-series and primary memory subsets |
-1.5 | | KIZ | 'T-helper 2 polarising' at '5 days' vs 'no stimulus' | cell type, sampling time point, stimulus | Transcription profiling by array of human CD4+T-cells, Th1/Th2 polarized time-series and primary memory subsets |
-1.5 | | KIZ | 'T-helper 1 polarising' at '5 days' vs 'no stimulus' | cell type, sampling time point, stimulus | Transcription profiling by array of human CD4+T-cells, Th1/Th2 polarized time-series and primary memory subsets |
-1.5 | | KIZ | 'Newcastle disease virus' at '8 hour' vs 'none' at '0 hour' | infect, time | Transcription profiling by array of human dendritic cells infected with Newcastle Disease Virus |
1.5 | | KIZ | 'astrocyte overexpressing 7 genes' vs 'glioblastoma cell line' | phenotype | Transcription profiling by array of human primary astrocytes, cancer stem cells derived from astrocytes overexpressing various oncogenic and iPSC-inducing factors, glioma stem cells and gliblastomat cell line to compare their expression profiles and tumor-initiating capabilities |
1.5 | | KIZ | 'BEZ235; 50 per cent inhibitory concentration' vs 'DMSO; ' | compound | Comparison of gene expression alterations induced by distinct PI3K inhibitors |
1.5 | | KIZ | 'type I diabetes mellitus' vs 'normal' | disease staging | Transcription profiling human whole blood from children with pre-type1diabetes |
-1.5 | | KIZ | 'metastatic prostate cancer' vs 'benign prostate tumor' | disease | Transcription profiling by array of human benign prostate, primary and metastatic prostate cancer samples to reveal signatures of metastatic progression |
-1.4 | | KIZ | ' neural stem cell' vs 'induced pluripotent stem cell' in 'normal' | cell type, disease | Human iPSC-Derived Cerebellar Neurons from a Patient with Ataxia-Telangiectasia Reveal Disrupted Gene Regulatory Networks |
1.4 | | KIZ | 'lapatinib; 500 nanomolar; 7 day' vs 'dimethyl sulfoxide; 1 day' | compound, time | RNA-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib |
-1.4 | | KIZ | 'doxycycline; 0.5 microgram per milliliter; Day 1 post Neurogenin induction' vs 'control' | compound, treatment | Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) |
1.4 | | KIZ | '18 day' vs '0 day' | time | RNA-Seq characterization of human H1-derived NPC differentiation timecourse |
-1.4 | | KIZ | 'Growth Medium' vs 'none' in 'systemic-onset juvenile idiopathic arthritis' | disease, stimulus | A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis [RNA-Seq] |
1.4 | | KIZ | 'JDM' vs 'normal' on 'Affymetrix HG-U133B' | disease | Transcription profiling by array of 12 human muscle diseases |
-1.4 | | KIZ | 'papillary thyroid carcinoma' vs 'normal' | disease | RNA-Sequencing of human papillary thyroid carcinomas |
1.4 | | KIZ | 'esophageal adenocarcinoma' vs 'normal' | disease, disease staging | Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's |
-1.4 | | KIZ | 'SUMO knockout' vs 'control' | genotype | Gene expression profile of SUMO knockout in human mammary epithelial cells |
-1.4 | | KIZ | '200 nanomolar; retinoic acid' vs '1 micromolar DMSO' | compound | Transcription profiling by array of human embryonic stem cells response to retinoic acid exposure |
-1.4 | | KIZ | 'stimulated' vs 'unstimulated' in 'none' | compound, treatment | Transcription profiling by array of stimulated or unstimulated human CD4+ T cells incubated with edelfosine |
1.4 | | KIZ | 'PLX4032; 500 nanomolar' vs 'DMSO' | compound | Parent vs. Induced drug tolerant cells Microarray Analysis |
-1.4 | | KIZ | 'APE1 RNAi' vs 'scrambled control' | RNA interference | RNAi knock down of the DNA-repair enzyme and transcriptional co-activator APE1 in human HeLa cells |
1.4 | | KIZ | 'valproic acid; 15 millimolar' vs 'control' at '1 day' | compound, sampling time point | RNA-seq of Primary Human Hepatocytes (PHH) exposed to Valproic Acid (VPA) for 3 days daily and 3 days daily exposure followed by 3 days washout. |
-1.4 | | KIZ | 'mesendoderm/endoderm progenitor cell' vs 'embryonic stem cell' | cell type | Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions |
-1.4 | | KIZ | '8 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
-1.4 | | KIZ | '786-0; renal adenocarcinoma; P01' vs '786-0; renal adenocarcinoma; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
-1.4 | | KIZ | 'AsPC-1; pancreatic adenocarcinoma; P10' vs 'AsPC-1; pancreatic adenocarcinoma; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
-1.4 | | KIZ | 'stimulated with interferon gamma and lipopolysaccharide' vs 'unstimulated' in 'EX00000246' at '6 hour' | compound, time, treatment | GPBAR1 agonism has a broad impact on blocking macrophage activation |
1.4 | | KIZ | 'hypoxia' vs 'normoxia' in 'SW982' | cell line, growth condition | Hypoxia and Intrinsic Transcriptomic Subtyping of Soft Tissue Sarcoma |
-1.4 | | KIZ | 'astrocyte overexpressing 4 genes' vs 'astrocyte' | phenotype | Transcription profiling by array of human primary astrocytes, cancer stem cells derived from astrocytes overexpressing various oncogenic and iPSC-inducing factors, glioma stem cells and gliblastomat cell line to compare their expression profiles and tumor-initiating capabilities |
-1.4 | | KIZ | 'insulin-like growth factor' at '24 hour' vs 'control' at '24 hour' | compound, time | Expression data from MCF-7 cells stimulated by Estrogen or IGF-I |
1.4 | | KIZ | 'PI-103' vs 'DMSO' | compound | Gene expression profiling upon PI3K inhibition using different inhibitors |
-1.4 | | KIZ | '6BIO' vs 'DMSO' in 'EPT1' | cell line, compound, time | Transcription profiling of effected genes by compound BIO,3G4 and knockdown of MED23 |
-1.4 | | KIZ | 'Newcastle disease virus' at '10 hour' vs 'none' at '10 hour' | infect, time | Transcription profiling by array of human dendritic cells infected with Newcastle Disease Virus |
1.3 | | KIZ | '4 day' vs '0 day' | time | RNA-Seq characterization of human H1-derived NPC differentiation timecourse |
-1.3 | | KIZ | 'Human gammaherpesvirus 4' at '4 day' vs 'none' at '0 day' | infect, time | Infection of naïve primary human B-lymphocytes with Epstein-Barr virus (EBV) – time course transcriptomic analysis in the pre-latent phase of viral infection |
-1.3 | | KIZ | 'adult; burn; middle stage' vs 'adult; control' | developmental stage, injury, sampling time point | Gene expression of blood samples from pediatric and adult patients with severe burns collected at an early and middle stage after injury. |
-1.3 | | KIZ | 'cisplatin; 100 micromolar' vs 'none' in 'scrambled siRNA' | RNA interference, compound | RNA-seq of human head and neck cancer cell line SQD9 knock-out for TMEM45A exposed to cisplatin |
1.3 | | KIZ | 'small activating RNA; 50 nanomolar' vs 'none; ' | RNA interference | Characterization of gene expression profiles induced by HIC-1 reactivation on breast cancer |
1.3 | | KIZ | 'autoantibodies against islet cells' vs 'normal' | disease staging | Transcription profiling human whole blood from children with pre-type1diabetes |
-1.3 | | KIZ | 'smoke' vs 'air control' at '6 hour' | growth condition, time | Transcription profiling by array of human bronchial epithelial cells after exposure to cigarette smoke |
-1.3 | | KIZ | 'Myc overexpression and SUMO knockout' vs 'control' | genotype | Gene expression profile of SUMO knockout in human mammary epithelial cells |
-1.3 | | KIZ | '2 micromolar retinoic acid' vs 'none' | compound | Transcription profiling by array of human embryonic stem cells response to retinoic acid exposure |
1.3 | | KIZ | 'colon adenocarcinoma' vs 'normal' | disease | RNA-seq of 21 sessile serrated colon adenoma/polyps, 10 hyperplastic polyps, 10 adenomas, 21 uninvolved colon and 20 control colon specimens |
1.3 | | KIZ | 'paediatric' vs 'foetal' in 'epithelial cell of small intestine' | cell type, developmental stage | Transcriptional profiling by array of intestinal epithelial cells from foetal and paediatric gut |
-1.3 | | KIZ | 'let-7 overexpression in HPAT5 knockout' vs 'let-7 overexpression in HPAT5 wild type' | genotype | Transcription profiling by array after let-7 overexpression in human embryonic stem cells with HPAT5 knockout |
-1.3 | | KIZ | 'S1 stimulation (French trial conditions)' at '48 hour' vs 'control' at '0 hour' | growth condition, time | Transcription profilin by array of human CD34+ hematopoietic progenitor cells grown under different conditions |
-1.3 | | KIZ | 'IGA glomerulonephritis' vs 'normal' | disease | Transcriptomic and proteomic profiling reveal insights of mesangial cell function in patients with IgA Nephropathy |
1.3 | | KIZ | '20 percent oxygen; old' vs '20 percent oxygen; young' | growth condition, phenotype | Transcription profiling of human lung fibroblasts at young and senescent stage grown at different oxygen levels |
-1.3 | | KIZ | '9 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
1.3 | | KIZ | 'lethal factor (anthrax toxin)' vs 'lacZ' | genotype | MKK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 cells. |
-1.3 | | KIZ | 'lurbinectedin; 10 nanomolar' vs 'none' | compound | Whole transcriptome profiling by microarray of monocytes stimulated with LPS and treated with trabectedin, lurbinectedin or doxorubicin |
-1.3 | | KIZ | 'Interleulin 1 beta' vs 'control' on 'Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]' | stimulus | Transcription profiling by array of human blood monocyte stimulated with various stimuli (control, MRP8, LPS, TNF, IL1) to study signalling pathways in phagocytic activation |
1.3 | | KIZ | 'chronic kidney disease' vs 'normal' in 'validation set' | cohort, disease | Development of gene expression profiles in human chronic kidney disease |
-1.3 | | KIZ | 'CD3 and CD28' vs 'none' | compound, disease | Transcription profiling by array of human CD3-positive T cells from patients with systemic lupus erythematosus |
-1.3 | | KIZ | 'cooked broccoli' at '1 minute' vs 'water' | growth condition, time | Transcription profiling of human colon Caco2 cells treated with extracts from broccoli that had been cooked for different lengths of time |
1.2 | | KIZ | 'tunicamycin; 4 microgram per milliliter' at '8 hour' vs 'none; ' at '8 hour' | compound, time | Transcription profiling by array of human immortalized B cells from unrelated individuals or twins after treatment with tunicamycin or thapsigargin |
1.2 | | KIZ | 'doxycycline-mediated expression of dominant-negative FOS' vs 'wild type' | phenotype | Transcription profiling of oesophageal adenocarcinoma by RNA-seq |
-1.2 | | KIZ | ' neural stem cell' vs 'induced pluripotent stem cell' in 'Ataxia-telangiectasia' | cell type, disease | Human iPSC-Derived Cerebellar Neurons from a Patient with Ataxia-Telangiectasia Reveal Disrupted Gene Regulatory Networks |
1.2 | | KIZ | 'ERBB2 siRNA' vs 'scrambled siRNA' | RNA interference | RNA-seq of OE19 cells treated with siNT or siERBB2 for 72 hours |
-1.2 | | KIZ | 'GATA6 R456C/+; Patient A' vs 'wild type genotype; H9' in 'definitive endoderm cell' | cell line, cell type, genotype, individual | RNA-seq of definitive endoderm and pancreatic progenitor cells derived in vitro from human pluripotent stem cells in order to study the role of transcription factor GATA6 in human pancreas development |
-1.2 | | KIZ | 'Human gammaherpesvirus 4' at '3 day' vs 'none' at '0 day' | infect, time | Infection of naïve primary human B-lymphocytes with Epstein-Barr virus (EBV) – time course transcriptomic analysis in the pre-latent phase of viral infection |
-1.2 | | KIZ | 'adult; burn; early stage' vs 'adult; control' | developmental stage, injury, sampling time point | Gene expression of blood samples from pediatric and adult patients with severe burns collected at an early and middle stage after injury. |
-1.2 | | KIZ | 'EIF2AK3 homozygous knockout' vs 'wild type' | phenotype | RNA-seq of human near-haploid cell line HAP1 with CRISPR-edited frameshift mutations |
1.2 | | KIZ | 'Barrett’s esophagus; non-dysplastic' vs 'normal' | disease, disease staging | Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's |
-1.2 | | KIZ | 'RNH1 knockout' vs 'wild type genotype' | genotype | Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient Human K562 cells |
-1.2 | | KIZ | 'Growth Medium' vs 'none' in 'normal' | disease, stimulus | A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis [RNA-Seq] |
-1.2 | | KIZ | 'HCC-2998; colon carcinoma; P10' vs 'HCC-2998; colon carcinoma; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
-1.2 | | KIZ | 'Staphylococcus aureus strain 10254' at '3 hour' vs 'none' at '0 hour' | time, treatment | Transcription profiling by array of human peripheral blood mononuclear cells after treatment with community-associated Staphylococcus aureus and incubation for different lengths of time |
-1.2 | | KIZ | 'ejaculatory azoospermia; Johnsen score count 5' vs 'normal; Johnsen score count 10' | disease, histology | Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis |
-1.2 | | KIZ | 'inflammatory breast cancer' vs 'normal' | disease | Expression Analysis of Microdissected Inflammatory Breast Cancer |
-1.2 | | KIZ | 'SKR6LR cells resistant to lapanitib' vs 'SKR6 cells with elevated HER2 expression' | phenotype | Nuclear factor kappa B activation-induced anti-apoptosis renders HER2 positive cells drug resistant and accelerates tumor growth |
-1.2 | | KIZ | 'CRISPR-Cas9 induced GNRH1 reporter; 27 day' vs 'wild type genotype; 20 day' | genotype, stimulus, time | RNA-Seq of GNRH1 neurons differentiated from human pluripotent stem cells |
-1.2 | | KIZ | 'ACO2-V5 overexpression #UD' vs 'empty vector' | genotype | Transcription profiling by array of HT29 colon carcinoma cells overexpressing mitochondrial aconitase ACO2 |
-1.2 | | KIZ | '2 micromolar; retinoic acid' vs '1 micromolar DMSO' | compound | Transcription profiling by array of human embryonic stem cells response to retinoic acid exposure |
-1.2 | | KIZ | 'Staphylococcus aureus strain 252' at '3 hour' vs 'none' at '0 hour' | time, treatment | Transcription profiling by array of human peripheral blood mononuclear cells after treatment with community-associated Staphylococcus aureus and incubation for different lengths of time |
-1.2 | | KIZ | 'long term estrogen deprived' vs 'control' in 'ZR75-1' | cell line, growth condition | Transcription profiling by array of human estrogen receptor positive breast cancer cell lines after long-term estrogen deprivation |
-1.2 | | KIZ | 'ACO2-V5 overexpression #C' vs 'empty vector' | genotype | Transcription profiling by array of HT29 colon carcinoma cells overexpressing mitochondrial aconitase ACO2 |
1.2 | | KIZ | 'P-bodies (cytosolic RNP granules)' vs 'pre-sorted fraction' | fraction | RNA-Seq of purified P-bodies from HEK293 cells |
-1.2 | | KIZ | 'docosahexaenoic acid; lipopolysaccharide' vs 'docosahexaenoic acid; vehicle' | clinical history, stimulus | Transcription profiling by array of human peripheral blood mononuclear cells from patients with hypertriglyceridemia after treatment with docosahexaenoic acid and/or lipopolysaccharide |
-1.2 | | KIZ | 'ejaculatory azoospermia; Johnsen score count 2' vs 'ejaculatory azoospermia; Johnsen score count 8' | disease, histology | Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis |
-1.2 | | KIZ | 'hyperglycemic condition' vs 'non-diabetic condition' | clinical information | Transcription profiling by array of human pancreatic beta cells transplanted into mice |
-1.2 | | KIZ | 'phorbol 13-acetate 12-myristate; 100 nanomolar; interleukin-4 and interleukin-13; 2 day' vs 'none; none; 0 day' | compound, stimulus, time | Transcriptional profiling of THP1-derived human macrophages with different stimuli |
-1.2 | | KIZ | 'Francisella tularensis Schu S4' vs 'uninfected' | infect | Transcription profiling by array of human peripheral blood mononuclear cells infected with Francisella tularensis |
-1.2 | | KIZ | 'S2 stimulation (British trial conditions)' at '48 hour' vs 'control' at '0 hour' | growth condition, time | Transcription profilin by array of human CD34+ hematopoietic progenitor cells grown under different conditions |
1.2 | | KIZ | 'rotenone; 50 nanomolar' at '4 week' vs 'vehicle; ' at '4 week' | compound, time | Transcriptome analysis of a chronic in vitro model of Parkinsonism |
-1.2 | | KIZ | 'EX00000246; stimulated with interferon gamma and lipopolysaccharide' vs 'none' at '6 hour' | compound, time, treatment | GPBAR1 agonism has a broad impact on blocking macrophage activation |
-1.2 | | KIZ | 'ejaculatory azoospermia; Johnsen score count 2' vs 'ejaculatory azoospermia; Johnsen score count 7' | disease, histology | Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis |
-1.2 | | KIZ | 'pancreatic adenocarcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
-1.2 | | KIZ | 'tumor' vs 'adjacent normal tissue' | sampling site | Transcription profiling of human papillary thyroid carcinoma and paired normal tissues |
-1.2 | | KIZ | '7 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
-1.2 | | KIZ | 'Salmonella typhimurium' vs 'mock' | infect | Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium |
-1.2 | | KIZ | 'IFNg-treated' vs 'untreated' | treatment | Expression data from primary human keratinocytes exposed to cytokines in vitro (IL-4, IL-13, IL-17A, IFN-alpha, IFN-gamma, TNF) |
1.2 | | KIZ | 'mutated IDH1' vs 'wild type' | genotype | Comparison of gene expression profiles of anaplastic glioma with or without the mutated IDH1/2 gene |
1.2 | | KIZ | 'P0 cells' vs 'untreated P4 cells' | passage, treatment | Transcription profiling by high throughput sequencing of human fetal differentiated P0 retinal pigment epithelial cells, mesenchymal P4 cells, and A-83-01 rescued P4 cells |
-1.2 | | KIZ | 'cocultured with activated T cells' vs 'control' in 'none' | compound, growth condition | Gene signature of CLL cells cultured with activated T cells or CD40L-expressing cells |
-1.1 | | KIZ | 'GATA6 R456C/+; Patient A' vs 'wild type genotype; H9' in 'progenitor cell of endocrine pancreas' | cell line, cell type, genotype, individual | RNA-seq of definitive endoderm and pancreatic progenitor cells derived in vitro from human pluripotent stem cells in order to study the role of transcription factor GATA6 in human pancreas development |
-1.1 | | KIZ | 'cycloheximide; 17beta-estradiol' vs 'DMSO control; 17beta-estradiol' | compound, growth condition | Transcription profiling by array of human MCF7 breast cancer cells after growth with cyclohexamide followed by treatment with 17beta-estradiol |
-1.1 | | KIZ | 'PI4KB homozygous knockout' vs 'wild type' | phenotype | RNA-seq of human near-haploid cell line HAP1 with CRISPR-edited frameshift mutations |
1.1 | | KIZ | 'miR-221/222' vs 'control' | RNA interference | Gene expression profiling of MCF10A (miR-221/222 vs control) |
-1.1 | | KIZ | 'medium with BMP4 and inhibitors' vs 'medium' | treatment | Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling |
1.1 | | KIZ | 'EPZ6438; 10x lowest cytotoxic concentration' vs 'DMSO' in 'KARPAS_422' at '6 day' | cell line, compound, time | Expression data from EZH2 inhibitor treated Non-Hodgkins Lymphoma cell lines |
-1.1 | | KIZ | 'p63 knockdown by siRNA' vs 'scrambled siRNA' in 'BxPC-3' | RNA interference, cell line | RNA-seq of human pancreatic cell lines, L3.6pl and BxPC-3, upon knockdown of p63 for 48 hours compared to siControl |
1.1 | | KIZ | 'beta-catenin knockdown' vs 'control' | genotype | Transcription profiling of human multiple myeloma cells ( MM1.S) cells with control or beta-catenin knockdown. |
-1.1 | | KIZ | 'HCT-116; colon carcinoma; P10' vs 'HCT-116; colon carcinoma; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
-1.1 | | KIZ | '786-0; renal adenocarcinoma; P10' vs '786-0; renal adenocarcinoma; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
1.1 | | KIZ | 'epithelial cell of small intestine' vs 'epithelial cell of large intestine' in 'paediatric' | cell type, developmental stage | Transcriptional profiling by array of intestinal epithelial cells from foetal and paediatric gut |
-1.1 | | KIZ | 'incubated with 10 ng/ml lipopolysaccharide' vs 'incubated in control medium' | growth condition | Transcription profiling of normal human monocytes in response to Aspergillus fumigatus |
1.1 | | KIZ | 'kidney transplant; tolerance' vs 'none; none' | clinical history, clinical information | Intragraft molecular pathways associated with tolerance induction in renal transplantation |
-1.1 | | KIZ | 'miR15a/miR16-1' vs 'empty vector' | genotype | Transcription profiling by array of MEG-01 cells transfected with miR-15a and miR-16-1 |
-1.1 | | KIZ | '6 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
1.1 | | KIZ | 'gamma tocotrienol; 40 micromolar' vs 'DMSO' | compound | Expression data of MCF-7 cells treated with gamma tocotrienol (g-T3) |
-1.1 | | KIZ | 'S2 stimulation (British trial conditions)' at '72 hour' vs 'control' at '0 hour' | growth condition, time | Transcription profilin by array of human CD34+ hematopoietic progenitor cells grown under different conditions |
-1.1 | | KIZ | 'colorectal carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
-1.1 | | KIZ | 'Alzheimers disease' vs 'normal' in 'entorhinal cortex' | disease, organism part | Microarray analysis of six brain areas from Alzheimers disease patients and normal individuals |
-1.1 | | KIZ | 'Ataxia-telangiectasia' vs 'normal' | disease | Ataxia-telangiectasia cerebellar cortex expression |
1.1 | | KIZ | 'Panc-2.12; PD032590; 15 milligram per kilogram' vs 'Panc-2.12; vehicle; ' | cell line, compound | Expression Data from 24 orthotopic tumors grown in the pancreas of mice +/- MEK inhibitor PD0325901 |
-1.1 | | KIZ | 'cocultured with CD40L- cells' vs 'control' in 'none' | compound, growth condition | Gene signature of CLL cells cultured with activated T cells or CD40L-expressing cells |
-1.1 | | KIZ | 'S1 stimulation (French trial conditions)' at '72 hour' vs 'control' at '0 hour' | growth condition, time | Transcription profilin by array of human CD34+ hematopoietic progenitor cells grown under different conditions |
-1.1 | | KIZ | 'TIA-1 and TIAR siRNA' vs 'control siRNA' | rna interference, RNA interference | Transcription profiling by array of HeLa cells with RNAi knockdown of T-cell intracellular antigen proteins |
-1.1 | | KIZ | 'trabectedin; 10 nanomolar' vs 'none' | compound | Whole transcriptome profiling by microarray of monocytes stimulated with LPS and treated with trabectedin, lurbinectedin or doxorubicin |
-1 | | KIZ | '6 hour' vs '0 hour' in 'MCF-10A-H1047R' | cell line, time | Knock-in of PIK3CA-H1047R into MCF-10A |
-1 | | KIZ | 'child; burn; middle stage' vs 'child; control' | developmental stage, injury, sampling time point | Gene expression of blood samples from pediatric and adult patients with severe burns collected at an early and middle stage after injury. |
-1 | | KIZ | 'breast cancer' vs 'normal' | disease | Gene expression profiling of LCM captured breast cancer cells |
-1 | | KIZ | 'HDAC1 homozygous knockout' vs 'wild type' | phenotype | RNA-seq of human near-haploid cell line HAP1 with CRISPR-edited frameshift mutations |
1 | | KIZ | 'serum deprivation' vs 'asynchronous growth' | growth condition | Transcription profiling by array of human T98G cells under growth arrest |
1 | | KIZ | '2 day' vs '0 day' | time | RNA-Seq characterization of human H1-derived NPC differentiation timecourse |
1 | | KIZ | 'EPZ6438; 10x lowest cytotoxic concentration' vs 'DMSO' in 'SUDHL6' at '6 day' | cell line, compound, time | Expression data from EZH2 inhibitor treated Non-Hodgkins Lymphoma cell lines |
1 | | KIZ | 'resistant to methotrexate' vs 'sensitive to methotrexate' | phenotype | Networking of differentially expressed genes in human MIA PaCa2 pancreatic cancer cells resistant to methotrexate |
1 | | KIZ | 'vemurafenib' vs 'DMSO' | compound | Expression data from BRAFV600E A375 melanoma cells treated with vehicle or vemurafenib |
1 | | KIZ | 'BKM120; 90 per cent inhibitory concentration (max)' vs 'DMSO; ' | compound | Comparison of gene expression alterations induced by distinct PI3K inhibitors |
-1 | | KIZ | 'Numb4 overexpression' vs 'control' in 'MDAMB231' | cell line, genotype | Expression profile of MDA-MB-231 and MCF7 cells stably transfected with GFP-Numb4, GFP-Numb5, GFP-Numb6 |
1 | | KIZ | 'WZ4002 resistant' vs 'control' | phenotype | Aberrant ERK signaling causes resistance to EGFR kinase inhibitors |
1 | | KIZ | 'C1013G/CXCR4 variant' vs 'control' | genotype | Gene expression profile of C1013G/CXCR4 mutated WM cells |
-1 | | KIZ | 'medium with BMP4' vs 'medium' | treatment | Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling |
1 | | KIZ | 'BRD4 inhibitor JQ1' vs 'none' in 'Mel202' | cell line, compound | Transcription profiling by array of uveal melanoma cell lines with wild type and mutant G-proteins (GNAQ or GNA11) in response to treatment with BRAD4 inhibitor JQ1 |
-1 | | KIZ | 'ochratoxin A; 130 nanomolar' vs 'none' at '1 day' | compound, time | Microarray mRNA data of RPTEC/TERT1 cells exposed to nephrotoxic chemicals ochratoxin A and potassium bromate |
-1 | | KIZ | 'KLF17 overexpression' at '24 day' vs 'wild type' at '0 day' | phenotype, time | RNA-seq of hESCs undergoing primed to naive-like resetting via exogenous KLF17 overexpression |
-1 | | KIZ | 'tuberculin' vs 'saline' | stimulus | Transcriptional profiling of the tuberculin skin test in individuals cured of active tuberculosis disease (RNA-Seq) |
-1 | | KIZ | 'lipopolysaccharide; 100 nanogram per milliliter' vs 'none' in 'wild type' | compound, genotype | Transcription profiling by array of human THP-1 cells overexpressing or silenced for GAM after treatment with lipopolysaccharide |
1 | | KIZ | 'UV' vs 'none' in '(no brct expression) GFP control' | phenotype, stimulus | Transcriptional profiling by array of U2OS cells overexpressing the BRCT domain of PARP1 after UV radiation |
-1 | | KIZ | '154; 0.4 micromolar' vs 'DMSO' | compound | Development of a small molecule for treatment of castration resistant prostate cancer via androgen receptor and IL6/STAT3 pathways |
1 | | KIZ | 'ICG-001; 10 micromolar' vs 'DMSO' at '24 hour' | compound, time | Expression data from AsPC1 cells treated with ICG-001 |
1 | | KIZ | 'doxycycline' vs 'none' in 'Caki1' | cell line, compound | RNA-seq upon PAX8 knockdown in Renal Cell Carcinoma cell lines |
1 | | KIZ | 'CB-5083; 5 micromolar' vs 'dimethyl sulfoxide' in 'resistant to CB-5083' | compound, phenotype | RNA-seq of human ovarian cancer cell line OVSAHO parental and CB-5083-resistant cells |
-1 | | KIZ | 'PRPF8' vs 'control' | RNA interference | Regulation of constitutive and alternative messenger RNA splicing across the human transcriptome by PRPF8 is determined by 5' splice site strength |
1 | | KIZ | 'Panc-2.13; CI-1040; 2 millimolar' vs 'Panc-2.13; vehicle; ' | cell line, compound | Expression Data from 22 human pancreatic cancer cell lines grown in triplicates +/- MEK inhibitor CI-1040 |
-1 | | KIZ | 'MAGEA3 shRNA' vs 'scrambled shRNA' | RNA interference | RNA-seq of the human HCC cell line PLC5 after 72 hours treatment with either MAGEA3 shRNA or Scramble control |
-1 | | KIZ | 'SARS coronavirus Urbani ΔORF6 mutant' vs 'mock' at '72 hour' | infect, time | Time course analysis of icSARS CoV Urbani or icSARS deltaORF6 infected Calu-3 2B4 bronchial epithelial cells |
1 | | KIZ | 'AQM' vs 'normal' on 'Affymetrix HG-U133A' | disease | Transcription profiling by array of 12 human muscle diseases |
1 | | KIZ | 'hypoxia' vs 'normoxia' at '7 day' | environmental stress, time | Transcription profiling by array of the effect of hypoxia in tumour-initiating cells derived from a colorectal cancer patient |
1 | | KIZ | 'Snail overexpression' vs 'control' | treatment | Expression data from breast cancer cell line MCF-7 with ectopic expression of the transcription factor Snail |
-1 | | KIZ | 'MOF siRNA' vs 'control siRNA' in 'doxycycline-mediated repression of FOXP3' | RNA interference, phenotype | Transcription profiling by array of human MCF-7 breast cancer cells with FOXP3 target gene expression with and without MOF knockdown |
-1 | | KIZ | 'stimulated with interferon gamma and lipopolysaccharide' vs 'unstimulated' in 'EX00000246' at '24 hour' | compound, time, treatment | GPBAR1 agonism has a broad impact on blocking macrophage activation |
-1 | | KIZ | 'Staphylococcus aureus strain Col' at '2 hour' vs 'none' at '0 hour' | time, treatment | Transcription profiling by array of human peripheral blood mononuclear cells after treatment with community-associated Staphylococcus aureus and incubation for different lengths of time |
-1 | | KIZ | 'SARS coronavirus Urbani' vs 'mock' at '54 hour' | infect, time | Time course analysis of icSARS CoV Urbani or icSARS deltaORF6 infected Calu-3 2B4 bronchial epithelial cells |
-1 | | KIZ | 'replicatively senescent; grown until growth arrest' vs 'spontaneously immortal cells; control' | phenotype, treatment | Pathway Profiling of Replicative and Induced Senescence |
-1 | | KIZ | 'vehicle; lipopolysaccharide' vs 'vehicle; vehicle' | clinical history, stimulus | Transcription profiling by array of human peripheral blood mononuclear cells from patients with hypertriglyceridemia after treatment with docosahexaenoic acid and/or lipopolysaccharide |
-1 | | KIZ | 'phorbol 13-acetate 12-myristate; 100 nanomolar; interleukin-4; 2 day' vs 'none; 3 day' in 'none; none; 0 day' | compound, stimulus, time | Transcriptional profiling of THP1-derived human macrophages with different stimuli |
-1 | | KIZ | 'cultured skin substitute; 28 day' vs 'skin; 0 day' | organism part, time | Transcription profiling by array of human grafted engineered skin substitutes |
1 | | KIZ | 'erythroleukemia; ZRSR2 shRNA' vs 'normal' | disease, genotype | RNA-seq of bone marrow from patients with myelodysplastic syndrome |
-1 | | KIZ | 'Mycobacterium tuberculosis' vs 'none' in 'adult' | developmental stage, infect | Multifaceted dysfunction of infant airway macrophages in response to Mycobacterium tuberculosis |
1 | | KIZ | 'induced pluripotent stem cell' vs 'cardiac muscle cell' | cell type | Gene expression profiling by RNA-seq of human iPSC and iPSC-derived cardiomyocytes from an Yoruban individual (NA19101) |
1 | | KIZ | '100 microgram per milliliter trovafloxacin' vs 'none' | compound | Transcription profiling by array of human primary hepatocytes treated with trovafloxacin |
-1 | | KIZ | 'glioblastoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
-1 | | KIZ | 'non-inflammatory breast cancer' vs 'normal' | disease | Expression Analysis of Microdissected Inflammatory Breast Cancer |
-1 | | KIZ | '7 hour after induction of differentiation' vs '0 hour' | time | Transcription profiling time series of human mesenchymal stem cells after induction of differentiation |
-1 | | KIZ | 'rotenone; 50 nanomolar' at '1 week' vs 'vehicle; ' at '1 week' | compound, time | Transcriptome analysis of a chronic in vitro model of Parkinsonism |
1 | | KIZ | 'non metastasis; tumor' vs 'non metastasis; normal adjacent tissue' | clinical information, sampling site | Gene expression profile of primary colorectal tumors with and without distant metastasis |
-1 | | KIZ | 'S1 stimulation (French trial conditions)' at '96 hour' vs 'control' at '0 hour' | growth condition, time | Transcription profilin by array of human CD34+ hematopoietic progenitor cells grown under different conditions |
-1 | | KIZ | 'zebularine; 1000 micromolar' vs 'none' | compound | Treatment of renal cell carcinoma cell line A-498 with zebularine |
-1 | | KIZ | '3 h DRB 8 min 4sU' vs 'untreated' | treatment | 4sUDRB-seq: measuring transcription elongation and initiation genomewide |